Evidence map›Paper›PMID 33800457›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Novel Cationic Meso-Arylporphyrins and Their Antiviral Activity against HSV-1.

Kseniya A Zhdanova, Inga O Savelyeva, Artem V Ezhov, Andrey P Zhdanov, Konstantin Yu Zhizhin, Andrey F Mironov, Natal'ya A Bragina, Alla A Babayants, Irina S Frolova, Nadezhda I Filippova and 2 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Photosensitizing Antivirals.Molecules (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kseniya A ZhdanovaMIREA-Russian Technological University, Vernadsky Prospect 86, Moscow 119571, Russia.
Inga O SavelyevaMIREA-Russian Technological University, Vernadsky Prospect 86, Moscow 119571, Russia.
Artem V EzhovMIREA-Russian Technological University, Vernadsky Prospect 86, Moscow 119571, Russia.
Andrey P ZhdanovKurnakov Institute of General and Inorganic Chemistry of the Russian Academy of Sciences, Leninskii Pr. 31, Moscow 117907, Russia.ORCID 0000-0003-4083-386X
Konstantin Yu ZhizhinMIREA-Russian Technological University, Vernadsky Prospect 86, Moscow 119571, Russia.
Andrey F MironovMIREA-Russian Technological University, Vernadsky Prospect 86, Moscow 119571, Russia.
Natal'ya A BraginaMIREA-Russian Technological University, Vernadsky Prospect 86, Moscow 119571, Russia.
Alla A BabayantsGamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str. 18, Moscow 123098, Russia.
Irina S FrolovaGamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str. 18, Moscow 123098, Russia.
Nadezhda I FilippovaGamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str. 18, Moscow 123098, Russia.
Nadezhda N ScliankinaGamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str. 18, Moscow 123098, Russia.
Olga N ScheglovitovaGamaleya Research Center of Epidemiology and Microbiology, Gamaleya Str. 18, Moscow 123098, Russia.

Funding

Russian Science Foundation 20-73-00286
6 · The paper itself

Abstract

This work is devoted to the search for new antiherpes simplex virus type 1 (HSV-1) drugs among synthetic tetrapyrroles and to an investigation of their antiviral properties under nonphotodynamic conditions. In this study, novel amphiphilic 5,10,15,20-tetrakis(4-(3-pyridyl-

Indexed as

anti-HSV-1antiviral activitycationic porphyrinsdark antiviral activity of porphyrinsnanovehiclesPluronic F127synthesisviruses

Identifiers

PMID33800457
PMCPMC7999199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.